subcutaneous injection


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.subcutaneous injection - an injection under the skin
injection, shot - the act of putting a liquid into the body by means of a syringe; "the nurse gave him a flu shot"
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
Tokyo, Japan, June 26, 2006 - (JCN) - Novartis Pharma Japan announced on June 26 that it has filed a new drug application for Xolair for Subcutaneous Injection 150mg, its proprietary agent for treating bronchial asthma (BA), with the Ministry of Health, Labor and Welfare.
Both of these compounds are currently being administered by subcutaneous injection and the company intends to investigate alternative means of delivery for potential application in the future.
* Recommended Dosage: Subcutaneous 40-mg loading dose, followed by a 10-mg subcutaneous injection daily, adjusting dose based on serum insulin-like growth factor-I (IGF-I) levels, with dose not to exceed 30 mg a day.
After the subcutaneous injection was given or the pump infusion was started, the patients received intravenous insulin at a rate needed to maintain the plasma glucose at 130 mg/dL.
Rebif is taken by subcutaneous injection (just under the skin) 3 times a week at a 44-microgram dose.
Kahn of San Francisco General Hospital and his colleagues provided soluble CD4 to 42 AIDS and ARC patients by intravenous, intramuscular or subcutaneous injection for 11 weeks.
Emgality offers a once-monthly, self-administered, subcutaneous injection. Emgality is contraindicated in patients with serious hypersensitivity to galcanezumab-gnlm or to any of the excipients.
and Eisai's subsidiary for gastrointestinal diseases EA Pharma Co., Ltd.announced that the autoinjection delivery system for HUMIRA (generic name: adalimumab [recombinant], "HUMIRA"), HUMIRA for Subcutaneous Injection 40 mg Pen 0.4 mL and HUMIRA for Subcutaneous Injection 80 mg Pen 0.8 mL, was listed in the National Health Insurance Drug Price Standard on 30th May.
Pharmaceutical company Indivior PLC (LON:INDV) said on Friday that it has submitted a New Drug Submission (NDS) with Health Canada's Therapeutic Drugs Directorate for SUBLOCADE (buprenorphine extended-release) subcutaneous injection for the treatment of moderate to severe opioid use disorder (OUD) including counseling and psychosocial support.
These syringe and cartridge based injectables also reduce the possibility of errors in preparing and administering a subcutaneous injection. Pain and discomfort are also reduced with the use of short, and very fine bore, needles.

Full browser ?